Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer
作者
In Gyu Hwang,Joung-Soon Jang,Sung Yong Oh,Myung Hwan Rho,Suee Lee,Young Suk Park,Joon Oh Park,Eun Mi Nam,Hyo Rak Lee,Hyun Jung Jun,Kyong‐Choun Chi